ACER
Acer Therapeutics Inc
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Acer Therapeutics Inc. is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. The company's pipeline includes treatments for various rare genetic disorders.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2023 | $371790.0 | $13.38m | - | $133157.0 | 0.00% | 0.99% |
Company Impact
Help us evaluate Acer Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.